Monopar Therapeutics Inc (MNPR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Operating Expenses | 1,575 | 1,789 | 1,723 | 1,912 | 2,066 |
| Operating Income | -1,575 | -1,789 | -1,723 | -1,912 | -2,066 |
| Other Income | 271 | 74 | 82 | 98 | 112 |
| Pre-tax Income | -1,304 | -1,715 | -1,641 | -1,814 | -1,954 |
| Net Income Continuous | -1,304 | -1,715 | -1,641 | -1,814 | -1,954 |
| Net Income | $-1,304 | $-1,715 | $-1,641 | $-1,814 | $-1,954 |
| EPS Basic Total Ops | -0.37 | -0.49 | -0.51 | -0.60 | -0.69 |
| EPS Basic Continuous Ops | -0.37 | -0.49 | -0.51 | -0.60 | -0.69 |
| EPS Diluted Total Ops | -0.37 | -0.49 | -0.51 | -0.60 | -0.69 |
| EPS Diluted Continuous Ops | -0.37 | -0.49 | -0.51 | -0.60 | -0.69 |
| EPS Diluted Before Non-Recurring Items | -0.37 | -0.50 | -0.50 | N/A | N/A |
| EBITDA(a) | $-1,575 | $-1,789 | $-1,723 | $-1,912 | $-2,066 |